NCT00383916

Study Comparing 2 Different Formulations of Pantoprazole in Healthy Adults.

An Open-Label, Single-Dose, Randomized, 2-Period, Crossover, Bioequivalence Study Between the Altana Formulation of Pantoprazole Delayed-Release Granules and the Wyeth Formulation of Pantoprazole Delayed-Release Granules in Healthy Subjects.

• Status: Completed
• Phase: Phase 1
• Study type: Interventional
• Enrollment: —
• Sponsor: Wyeth is now a wholly owned subsidiary of Pfizer · Industry
• Sex: All
• Age: 18 Years – 50 Years
• Healthy volunteers: Accepted

Summary

A study comparing 2 different investigational formulations of pantoprazole in healthy adults.

Detailed description

open-label, single-dose, randomized, 2-period, 2-sequence, crossover, inpatient bioequivalence study

Conditions

• Healthy Subjects

Interventions

Type	Name	Description
DRUG	pantoprazole

Timeline

• Start date: 2006-10-01
• Completion: 2006-10-01
• First posted: 2006-10-04
• Last updated: 2007-03-08